Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof

Details for Australian Patent Application No. 2006211037 (hide)

Owner GlycArt Biotechnology AG

Inventors Umana, Pablo; Mossner, Ekkehard

Agent Davies Collison Cave

Pub. Number AU-B-2006211037

PCT Pub. Number WO2006/082515

Priority 60/650,115 07.02.05 US

Filing date 7 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 24 May 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/082515 Priority application(s): WO2006/082515

24 May 2012 Application Accepted

  Published as AU-B-2006211037

23 August 2012 Alteration of Name

  The name of the applicant has been altered to Roche GlycArt AG

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006211039-PYY agonists and uses thereof

2006211033-Novel salt form of a dopamine agonist